![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 42, 41198-41204, October 17, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


¶
From the
Departments of Internal Medicine and
Pharmacology and Molecular Biology, Washington University School of Medicine, St. Louis, Missouri 63110
C to U editing of the nuclear apolipoprotein B (apoB) transcript is mediated by a core enzyme containing a catalytic deaminase, apobec-1, and an RNA binding subunit, apobec-1 complementation factor (ACF). ACF expression is predominantly nuclear, including mutant proteins with deletions of a putative nuclear localization signal. We have now identified a novel 41-residue motif (ANS) in the auxiliary domain of ACF that functions as an authentic nuclear localization signal. ANS-green fluorescence protein and ANS-
-galactosidase chimeras were both expressed exclusively in the nucleus, whereas wild-type chimeras or an ACF deletion mutant lacking the ANS were cytoplasmic. Nuclear accumulation of ACF is transcription-dependent, temperature-sensitive, and reversible, features reminiscent of a shuttling protein. ACF relocates to the cytoplasm after actinomycin D treatment, an effect blocked by the CRM1 inhibitor leptomycin B. Heterokaryon assays confirmed directly that ACF shuttles in vivo. ACF binds to the protein carrier, transportin 2 in vivo, and colocalizes to the nucleus as determined by confocal microscopy. Co-immunoprecipitation experiments revealed that transportin 2 binds directly to the ANS motif. These data suggest that directed nuclear localization and compartmentalization of the core complex of the apoB RNA editing enzyme is regulated through a dominant targeting sequence (ANS) contained within ACF.
Received for publication, March 23, 2003 , and in revised form, July 21, 2003.
* This work was supported by National Institutes of Health Grants HL-38180 and DK-56260 and Digestive Disease Research Core Center Grant DK-52574 (particularly the Morphology Core). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed. Fax: 314-362-2033; E-mail: nod{at}im.wustl.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. W. Gaston, M. A. T. Rubio, J. L. Spears, I. Pastar, F. N. Papavasiliou, and J. D. Alfonzo C to U editing at position 32 of the anticodon loop precedes tRNA 5' leader removal in trypanosomatids Nucleic Acids Res., November 29, 2007; 35(20): 6740 - 6749. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Chen, T. L. Eggerman, and A. P. Patterson ApoB mRNA editing is mediated by a coordinated modulation of multiple apoB mRNA editing enzyme components Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G53 - G65. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Lehmann, C. A. Galloway, M. P. Sowden, and H. C. Smith Metabolic regulation of ApoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor Nucleic Acids Res., July 4, 2006; 34(11): 3299 - 3308. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kim and P. W. Tucker A Regulated Nucleocytoplasmic Shuttle Contributes to Bright's Function as a Transcriptional Activator of Immunoglobulin Genes. Mol. Cell. Biol., March 1, 2006; 26(6): 2187 - 2201. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Blanc, J. O. Henderson, E. P. Newberry, S. Kennedy, J. Luo, and N. O. Davidson Targeted Deletion of the Murine apobec-1 Complementation Factor (acf) Gene Results in Embryonic Lethality Mol. Cell. Biol., August 15, 2005; 25(16): 7260 - 7269. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |